title: Serotonin transporter gene polymorphisms and platelet [3H] paroxetine binding in premenstrual dysphoria.
abstract: The purpose of this study was to investigate if women with premenstrual dysphoria differ from controls with respect to the number of platelet serotonin transporters, and with respect to three polymorphisms in the gene coding for the serotonin transporter: a 44 base pair insertion/deletion in the promoter region, a variable number of tandem repeats in the second intron, and a single nucleotide polymorphism in the 3' untranslated region. Also, the possible relationship between the three polymorphisms and platelet serotonin transporter density was analyzed. The density of platelet [(3)H]paroxetine binding sites was significantly lower in women with premenstrual dysphoria than in controls, but patients and controls did not differ with respect to allele or genotype frequency for any of the three polymorphisms examined. A significant association between the number of platelet serotonin transporters and the promoter polymorphism was observed, subjects being homozygous for the short (deletion) variant having higher platelet serotonin transporter density than subjects carrying the long (insertion) allele. The results support the assumption that serotonin-related psychiatric disorders-such as premenstrual dysphoria-may be associated with a reduction in platelet [(3)H]paroxetine binding, but argue against the notion that this reduction is due to certain variants of the serotonin transporter gene being more common in patients than in controls.
authors.affiliation: Department of Pharmacology, Göteborg University, Sweden. jonas.melke@pharm.gu.se
authors.forename: J
authors.initials: J
authors.lastname: Melke
authors.forename: L
authors.initials: L
authors.lastname: Westberg
authors.forename: M
authors.initials: M
authors.lastname: Landén
authors.forename: C
authors.initials: C
authors.lastname: Sundblad
authors.forename: O
authors.initials: O
authors.lastname: Eriksson
authors.forename: F
authors.initials: F
authors.lastname: Baghei
authors.forename: R
authors.initials: R
authors.lastname: Rosmond
authors.forename: E
authors.initials: E
authors.lastname: Eriksson
authors.forename: A
authors.initials: A
authors.lastname: Ekman
mesh_terms: D000293:Adolescent; D000328:Adult; D001792:Blood Platelets / Q000378:metabolism*; D002352:Carrier Proteins / Q000235:genetics*; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D008562:Membrane Glycoproteins / Q000235:genetics*; D026901:Membrane Transport Proteins; D008875:Middle Aged; D009419:Nerve Tissue Proteins; D017374:Paroxetine / Q000378:metabolism*; D011110:Polymorphism, Genetic; D011293:Premenstrual Syndrome / Q000235:genetics / Q000378:metabolism*; D012701:Serotonin / Q000235:genetics / Q000378:metabolism; D050486:Serotonin Plasma Membrane Transport Proteins; D017367:Selective Serotonin Reuptake Inhibitors / Q000378:metabolism
chemical_list: D002352:Carrier Proteins; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D017374:Paroxetine; D012701:Serotonin; D050486:Serotonin Plasma Membrane Transport Proteins; D017367:Selective Serotonin Reuptake Inhibitors; C493230:SLC6A4 protein, human